NRXP:NASDAQ, NRx Pharmaceuticals, Inc.

NRXP stock overview

NRx Pharmaceuticals, Inc. (NRXP:NASDAQ) closed at $2.59 on October 14, 2026, down 4.07% on the day. The stock trades 48.8% below its 52-week high of $5.06 and 59.9% above its 52-week low of $1.62. Over the past year, it lost 18.3%. NRx Pharmaceuticals, Inc. is part of the Health Care sector.

Key figures

Price
$2.59
Day change
-4.07%
Volume
696,134
Average volume
839,509
Market cap
112M+
52-week range
$1.62 – $5.06
50-day average
$3.25
200-day average
$2.96

Performance

5D 1M 3M 6M 1Y
-9.12% -23.82% -39.34% -19.06% -18.30%

Price action over the past year

In 252 trading sessions since October 14, 2025, NRXP closed higher on 118 days (47%). Its best day was May 26, 2026 (+33.85%) and its worst was November 17, 2025 (-15.26%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

NRXP news

About NRx Pharmaceuticals, Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Find more stocks like NRXP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.